Increased frequency of antigen-specific CD8+ cytotoxic T lymphocytes infiltrating an epstein-barr virus-associated gastric carcinoma

Journal of Clinical Investigation

Volumn 104, Issue 2, 1999, Pages 163-171

  Kuzushima, Kiyotaka ^a   Nakamura, Shigeo ^a   Nakamura, Tsuneya ^a   Yamamura, Yoshitaka ^a   Yokoyama, Naoaki ^a   Fujita, Masatoshi ^a   Kiyono, Tohru ^a   Tsurumi, Tatsuya ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 1; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CASE REPORT; CELL INFILTRATION; CELL TRANSFORMATION; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA;

EID: 0032732363     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6062     Document Type: Article

References (30)

1. Rickinson, A.B., and Moss, D.J. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-431.
2. Lee., S.P., Tierney, R.J., Thomas, W.A., Brooks, J.M., and Rickinson, A.B. 1997. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J. Immunol. 158:3325-3334.
3. Steven, N.M., et al. 1997. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J. Exp. Med. 185:1605-1617.
4. Khanna, R., Burrows, S.R., Nicholls, J., and Poulsen, L.M. 1998. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 super-type-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur.J. Immunol. 28:451-458.
5. Rickinson, A.B., and Kieff, E. 1996. Epstein-Barr virus. In Fields virology. Volume 2, 3rd edition. B.N. Fields, D.M. Knipe, and P.M. Howley, editors. Lippincott-Raven Publishers. Philadelphia, PA. 2397-2446.
6. Kanegane, H., et al. 1998. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood. 91:2085-2091.
7. Shibata, D., et al. 1991. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Am. J. Pathol. 139:469-474.
8. Shibata, D., and Weiss, L.M. 1992. Epstein-Barr virus-associated gastric adenocarcinomas. Am. J. Pathol. 140:769-774.
9. Oda, K., et al. 1993. Association of Epstein-Barr virus with gastric carcinoma lymphoid stroma. Am. J. Pathol. 143:1063-1071.
10. Tokunaga, M., et al. 1993. Epstein-Barr virus in gastric carcinoma. Am. J. Pathol. 143:1250-1254.
11. Imai, S., et al. 1994. Gastric carcinoma: monoclonal epithelial cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA. 91:9131-9135.
12. Nakamura, S., Ueki, T., Yao, T., and Tsuneyoshi, M. 1994. Epstein-Barr virus in gastric carcinoma with lymphoid stroma: special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer. 73:2239-2249.
13. Saiki, Y., Ohtani, H., Naito, Y., Miyazawa, M., and Nagura, H. 1996. Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes. Lab. Invest. 75:67-76.
14. Sugiura, M., et al. 1996. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumor cells. Br. J. Cancer. 74:625-631.
15. Lertprasertsuke, N., and Tsutsumi, Y. 1989. Gastric carcinoma with lymphoid stroma. Analysis using mucin histochemistry and immunohistochemistry. Virchows Arch. A Pathol. Anat. Histopathol. 414:231-241.
16. Telenti, A., Marshall, W.F., and Smith, T.F. 1990. Detection of Epstein-Barr virus by polymerase chain reaction. J. Clin. Microbiol. 28:2187-2190.
17. Chen, F., et al. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt's lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:3752-3758.
18. Kobashi, Y., et al. 1996, Inconsistent association of Epstein-Barr virus with CD56(NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathology. 28:111-120.
19. Kuzushima, K., et al. 1996. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin. Exp. Immunol. 103:192-198.
20. Moretta, A., Pantaleo, G., Moretta, L., Cerottini, J.D., and Mingari, M.C. 1983. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity. J. Exp. Med. 157:743-754.
21. Blake, N., et al. 1997. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (gly-ala)-containing protein requires exogenous processing. Immunity. 7:791-802.
22. Levitskaya, J., et al. 1995. Inhibition of antigen processing by the internal repeat region of Epstein-Barr virus nuclear antigen-1. Nature. 375:685-688.
23. Ikeda-Moore, Y., et al. 1997. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1. J. Immunol. 159:6242-6252.
24. Waldrop, S.L., Pitcher, C.J., Perterson, D.M., Maino, V.C., and Picker, L.J. 1997. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry. J. Clin. Invest. 99:1739-1750.
25. + T lymphocytes secreting tumor necrosis factor α in response to HLA-A2.1-binding melanoma and viral peptide antigens. J. Immunol. Methods. 191:131-142.
26. Sakai, K., et al. 1987. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens. J. Natl. Cancer Inst. 79:923-932.
27. Kienzle, N., et al. 1988. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J. Virol. 72:6614-6620.
28. Lindermann, J., and Klein, P.A. 1967. Viraloncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J. Exp. Med. 126:93-108.
29. Kobayashi, H., et al. 1969. Modification in growth of transplantable rat tumors exposed to friend virus. J. Natl. Cancer Inst. 48:2975-2980.
30. Boon, T., Cerottini, J.-C., Eynde, B.V.D., Bruggen, P.V.D., and Pel, A.V. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.